The global Nuclear Medicine Isotopes market size was valued at US$ 4.56 billion in 2024 and is projected to reach US$ 7.23 billion by 2030, at a CAGR of 8.0% during the forecast period 2024-2030.
The United States Nuclear Medicine Isotopes market size was valued at US$ 1.45 billion in 2024 and is projected to reach US$ 2.23 billion by 2030, at a CAGR of 7.4% during the forecast period 2024-2030.
Nuclear medicine isotopes are radioactive materials used in diagnostic imaging and therapeutic applications in nuclear medicine.
The global Nuclear Medicine Isotopes market is growing rapidly, driven by increasing cancer treatment needs and diagnostic applications. In 2023, total production value reached US$ 4.2 billion, with diagnostic applications accounting for 65% of demand. The therapeutic isotopes segment is the fastest-growing at 9.5% annually. The market saw a 30% increase in demand for novel therapeutic isotopes in 2023, reflecting advances in targeted therapy. Diagnostic isotopes dominate with a 70% market share, while therapeutic isotopes are growing at 10% annually. North America leads with a 45% market share, while Asia Pacific is the fastest-growing region at 8.8% CAGR. The industry is focusing on developing new production methods, with a 35% growth in R&D investments for supply chain reliability.
Report Overview
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use. In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Nuclear Medicine Isotopes Market provides a deep insight into the global Nuclear Medicine Isotopes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Isotopes Market, Nuclear Medicine Isotopes Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, Nuclear Medicine Isotopes Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine Isotopes market in any manner.
Global Nuclear Medicine Isotopes Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- NRG
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- IRE
- Nordion
- Curium Pharma
- Cambridge Isotope Laboratories
- Eckert & Ziegler Strahlen
- Polatom
- Center of Molecular Research
- China National Nuclear Corporation
- Urenco
- LANL
- Shanghai Engineering Research Center
- IDB Holland
- NHTC
- Linde
- ORNL
- SI Science
Market Segmentation (by Type)
- Stable Isotopes
- Radioisotopes
Market Segmentation (by Application)
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Medicine Isotopes Market
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nuclear Medicine Isotopes
1.2 Key Market Segments
1.2.1 Nuclear Medicine Isotopes Segment by Type
1.2.2 Nuclear Medicine Isotopes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nuclear Medicine Isotopes Market Overview
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Isotopes Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Medicine Isotopes Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nuclear Medicine Isotopes Market Competitive Landscape
3.1 Global Nuclear Medicine Isotopes Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine Isotopes Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Medicine Isotopes Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Medicine Isotopes Sales Sites, Area Served, Product Type
3.6 Nuclear Medicine Isotopes Market Competitive Situation and Trends
3.6.1 Nuclear Medicine Isotopes Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Medicine Isotopes Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nuclear Medicine Isotopes Industry Chain Analysis
4.1 Nuclear Medicine Isotopes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nuclear Medicine Isotopes Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nuclear Medicine Isotopes Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Isotopes Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Medicine Isotopes Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Medicine Isotopes Price by Type (2019-2024)
7 Nuclear Medicine Isotopes Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Isotopes Market Sales by Application (2019-2024)
7.3 Global Nuclear Medicine Isotopes Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Medicine Isotopes Sales Growth Rate by Application (2019-2024)
8 Nuclear Medicine Isotopes Market Segmentation by Region
8.1 Global Nuclear Medicine Isotopes Sales by Region
8.1.1 Global Nuclear Medicine Isotopes Sales by Region
8.1.2 Global Nuclear Medicine Isotopes Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Medicine Isotopes Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Medicine Isotopes Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Medicine Isotopes Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Medicine Isotopes Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Medicine Isotopes Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 NRG
9.1.1 NRG Nuclear Medicine Isotopes Basic Information
9.1.2 NRG Nuclear Medicine Isotopes Product Overview
9.1.3 NRG Nuclear Medicine Isotopes Product Market Performance
9.1.4 NRG Business Overview
9.1.5 NRG Nuclear Medicine Isotopes SWOT Analysis
9.1.6 NRG Recent Developments
9.2 NTP Radioisotopes
9.2.1 NTP Radioisotopes Nuclear Medicine Isotopes Basic Information
9.2.2 NTP Radioisotopes Nuclear Medicine Isotopes Product Overview
9.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Product Market Performance
9.2.4 NTP Radioisotopes Business Overview
9.2.5 NTP Radioisotopes Nuclear Medicine Isotopes SWOT Analysis
9.2.6 NTP Radioisotopes Recent Developments
9.3 JSC Isotope
9.3.1 JSC Isotope Nuclear Medicine Isotopes Basic Information
9.3.2 JSC Isotope Nuclear Medicine Isotopes Product Overview
9.3.3 JSC Isotope Nuclear Medicine Isotopes Product Market Performance
9.3.4 JSC Isotope Nuclear Medicine Isotopes SWOT Analysis
9.3.5 JSC Isotope Business Overview
9.3.6 JSC Isotope Recent Developments
9.4 ANSTO
9.4.1 ANSTO Nuclear Medicine Isotopes Basic Information
9.4.2 ANSTO Nuclear Medicine Isotopes Product Overview
9.4.3 ANSTO Nuclear Medicine Isotopes Product Market Performance
9.4.4 ANSTO Business Overview
9.4.5 ANSTO Recent Developments
9.5 IRE
9.5.1 IRE Nuclear Medicine Isotopes Basic Information
9.5.2 IRE Nuclear Medicine Isotopes Product Overview
9.5.3 IRE Nuclear Medicine Isotopes Product Market Performance
9.5.4 IRE Business Overview
9.5.5 IRE Recent Developments
9.6 Nordion
9.6.1 Nordion Nuclear Medicine Isotopes Basic Information
9.6.2 Nordion Nuclear Medicine Isotopes Product Overview
9.6.3 Nordion Nuclear Medicine Isotopes Product Market Performance
9.6.4 Nordion Business Overview
9.6.5 Nordion Recent Developments
9.7 Curium Pharma
9.7.1 Curium Pharma Nuclear Medicine Isotopes Basic Information
9.7.2 Curium Pharma Nuclear Medicine Isotopes Product Overview
9.7.3 Curium Pharma Nuclear Medicine Isotopes Product Market Performance
9.7.4 Curium Pharma Business Overview
9.7.5 Curium Pharma Recent Developments
9.8 Cambridge Isotope Laboratories
9.8.1 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Basic Information
9.8.2 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product Overview
9.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product Market Performance
9.8.4 Cambridge Isotope Laboratories Business Overview
9.8.5 Cambridge Isotope Laboratories Recent Developments
9.9 Eckert and Ziegler Strahlen
9.9.1 Eckert and Ziegler Strahlen Nuclear Medicine Isotopes Basic Information
9.9.2 Eckert and Ziegler Strahlen Nuclear Medicine Isotopes Product Overview
9.9.3 Eckert and Ziegler Strahlen Nuclear Medicine Isotopes Product Market Performance
9.9.4 Eckert and Ziegler Strahlen Business Overview
9.9.5 Eckert and Ziegler Strahlen Recent Developments
9.10 Polatom
9.10.1 Polatom Nuclear Medicine Isotopes Basic Information
9.10.2 Polatom Nuclear Medicine Isotopes Product Overview
9.10.3 Polatom Nuclear Medicine Isotopes Product Market Performance
9.10.4 Polatom Business Overview
9.10.5 Polatom Recent Developments
9.11 Center of Molecular Research
9.11.1 Center of Molecular Research Nuclear Medicine Isotopes Basic Information
9.11.2 Center of Molecular Research Nuclear Medicine Isotopes Product Overview
9.11.3 Center of Molecular Research Nuclear Medicine Isotopes Product Market Performance
9.11.4 Center of Molecular Research Business Overview
9.11.5 Center of Molecular Research Recent Developments
9.12 China National Nuclear Corporation
9.12.1 China National Nuclear Corporation Nuclear Medicine Isotopes Basic Information
9.12.2 China National Nuclear Corporation Nuclear Medicine Isotopes Product Overview
9.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Product Market Performance
9.12.4 China National Nuclear Corporation Business Overview
9.12.5 China National Nuclear Corporation Recent Developments
9.13 Urenco
9.13.1 Urenco Nuclear Medicine Isotopes Basic Information
9.13.2 Urenco Nuclear Medicine Isotopes Product Overview
9.13.3 Urenco Nuclear Medicine Isotopes Product Market Performance
9.13.4 Urenco Business Overview
9.13.5 Urenco Recent Developments
9.14 LANL
9.14.1 LANL Nuclear Medicine Isotopes Basic Information
9.14.2 LANL Nuclear Medicine Isotopes Product Overview
9.14.3 LANL Nuclear Medicine Isotopes Product Market Performance
9.14.4 LANL Business Overview
9.14.5 LANL Recent Developments
9.15 Shanghai Engineering Research Center
9.15.1 Shanghai Engineering Research Center Nuclear Medicine Isotopes Basic Information
9.15.2 Shanghai Engineering Research Center Nuclear Medicine Isotopes Product Overview
9.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Product Market Performance
9.15.4 Shanghai Engineering Research Center Business Overview
9.15.5 Shanghai Engineering Research Center Recent Developments
9.16 IDB Holland
9.16.1 IDB Holland Nuclear Medicine Isotopes Basic Information
9.16.2 IDB Holland Nuclear Medicine Isotopes Product Overview
9.16.3 IDB Holland Nuclear Medicine Isotopes Product Market Performance
9.16.4 IDB Holland Business Overview
9.16.5 IDB Holland Recent Developments
9.17 NHTC
9.17.1 NHTC Nuclear Medicine Isotopes Basic Information
9.17.2 NHTC Nuclear Medicine Isotopes Product Overview
9.17.3 NHTC Nuclear Medicine Isotopes Product Market Performance
9.17.4 NHTC Business Overview
9.17.5 NHTC Recent Developments
9.18 Linde
9.18.1 Linde Nuclear Medicine Isotopes Basic Information
9.18.2 Linde Nuclear Medicine Isotopes Product Overview
9.18.3 Linde Nuclear Medicine Isotopes Product Market Performance
9.18.4 Linde Business Overview
9.18.5 Linde Recent Developments
9.19 ORNL
9.19.1 ORNL Nuclear Medicine Isotopes Basic Information
9.19.2 ORNL Nuclear Medicine Isotopes Product Overview
9.19.3 ORNL Nuclear Medicine Isotopes Product Market Performance
9.19.4 ORNL Business Overview
9.19.5 ORNL Recent Developments
9.20 SI Science
9.20.1 SI Science Nuclear Medicine Isotopes Basic Information
9.20.2 SI Science Nuclear Medicine Isotopes Product Overview
9.20.3 SI Science Nuclear Medicine Isotopes Product Market Performance
9.20.4 SI Science Business Overview
9.20.5 SI Science Recent Developments
10 Nuclear Medicine Isotopes Market Forecast by Region
10.1 Global Nuclear Medicine Isotopes Market Size Forecast
10.2 Global Nuclear Medicine Isotopes Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Medicine Isotopes Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Medicine Isotopes Market Size Forecast by Region
10.2.4 South America Nuclear Medicine Isotopes Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine Isotopes by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nuclear Medicine Isotopes Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Medicine Isotopes by Type (2025-2030)
11.1.2 Global Nuclear Medicine Isotopes Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Medicine Isotopes by Type (2025-2030)
11.2 Global Nuclear Medicine Isotopes Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Medicine Isotopes Sales (K Units) Forecast by Application
11.2.2 Global Nuclear Medicine Isotopes Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Isotopes Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Isotopes Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Nuclear Medicine Isotopes Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Medicine Isotopes Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Medicine Isotopes Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Isotopes as of 2022)
Table 10. Global Market Nuclear Medicine Isotopes Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Medicine Isotopes Sales Sites and Area Served
Table 12. Manufacturers Nuclear Medicine Isotopes Product Type
Table 13. Global Nuclear Medicine Isotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Medicine Isotopes
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine Isotopes Market Challenges
Table 22. Global Nuclear Medicine Isotopes Sales by Type (K Units)
Table 23. Global Nuclear Medicine Isotopes Market Size by Type (M USD)
Table 24. Global Nuclear Medicine Isotopes Sales (K Units) by Type (2019-2024)
Table 25. Global Nuclear Medicine Isotopes Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Medicine Isotopes Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Medicine Isotopes Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Medicine Isotopes Price (USD/Unit) by Type (2019-2024)
Table 29. Global Nuclear Medicine Isotopes Sales (K Units) by Application
Table 30. Global Nuclear Medicine Isotopes Market Size by Application
Table 31. Global Nuclear Medicine Isotopes Sales by Application (2019-2024) & (K Units)
Table 32. Global Nuclear Medicine Isotopes Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Medicine Isotopes Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Medicine Isotopes Market Share by Application (2019-2024)
Table 35. Global Nuclear Medicine Isotopes Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Medicine Isotopes Sales by Region (2019-2024) & (K Units)
Table 37. Global Nuclear Medicine Isotopes Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Medicine Isotopes Sales by Country (2019-2024) & (K Units)
Table 39. Europe Nuclear Medicine Isotopes Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Nuclear Medicine Isotopes Sales by Region (2019-2024) & (K Units)
Table 41. South America Nuclear Medicine Isotopes Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Nuclear Medicine Isotopes Sales by Region (2019-2024) & (K Units)
Table 43. NRG Nuclear Medicine Isotopes Basic Information
Table 44. NRG Nuclear Medicine Isotopes Product Overview
Table 45. NRG Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. NRG Business Overview
Table 47. NRG Nuclear Medicine Isotopes SWOT Analysis
Table 48. NRG Recent Developments
Table 49. NTP Radioisotopes Nuclear Medicine Isotopes Basic Information
Table 50. NTP Radioisotopes Nuclear Medicine Isotopes Product Overview
Table 51. NTP Radioisotopes Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. NTP Radioisotopes Business Overview
Table 53. NTP Radioisotopes Nuclear Medicine Isotopes SWOT Analysis
Table 54. NTP Radioisotopes Recent Developments
Table 55. JSC Isotope Nuclear Medicine Isotopes Basic Information
Table 56. JSC Isotope Nuclear Medicine Isotopes Product Overview
Table 57. JSC Isotope Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. JSC Isotope Nuclear Medicine Isotopes SWOT Analysis
Table 59. JSC Isotope Business Overview
Table 60. JSC Isotope Recent Developments
Table 61. ANSTO Nuclear Medicine Isotopes Basic Information
Table 62. ANSTO Nuclear Medicine Isotopes Product Overview
Table 63. ANSTO Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. ANSTO Business Overview
Table 65. ANSTO Recent Developments
Table 66. IRE Nuclear Medicine Isotopes Basic Information
Table 67. IRE Nuclear Medicine Isotopes Product Overview
Table 68. IRE Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. IRE Business Overview
Table 70. IRE Recent Developments
Table 71. Nordion Nuclear Medicine Isotopes Basic Information
Table 72. Nordion Nuclear Medicine Isotopes Product Overview
Table 73. Nordion Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Nordion Business Overview
Table 75. Nordion Recent Developments
Table 76. Curium Pharma Nuclear Medicine Isotopes Basic Information
Table 77. Curium Pharma Nuclear Medicine Isotopes Product Overview
Table 78. Curium Pharma Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Curium Pharma Business Overview
Table 80. Curium Pharma Recent Developments
Table 81. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Basic Information
Table 82. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product Overview
Table 83. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Cambridge Isotope Laboratories Business Overview
Table 85. Cambridge Isotope Laboratories Recent Developments
Table 86. Eckert and Ziegler Strahlen Nuclear Medicine Isotopes Basic Information
Table 87. Eckert and Ziegler Strahlen Nuclear Medicine Isotopes Product Overview
Table 88. Eckert and Ziegler Strahlen Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eckert and Ziegler Strahlen Business Overview
Table 90. Eckert and Ziegler Strahlen Recent Developments
Table 91. Polatom Nuclear Medicine Isotopes Basic Information
Table 92. Polatom Nuclear Medicine Isotopes Product Overview
Table 93. Polatom Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Polatom Business Overview
Table 95. Polatom Recent Developments
Table 96. Center of Molecular Research Nuclear Medicine Isotopes Basic Information
Table 97. Center of Molecular Research Nuclear Medicine Isotopes Product Overview
Table 98. Center of Molecular Research Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Center of Molecular Research Business Overview
Table 100. Center of Molecular Research Recent Developments
Table 101. China National Nuclear Corporation Nuclear Medicine Isotopes Basic Information
Table 102. China National Nuclear Corporation Nuclear Medicine Isotopes Product Overview
Table 103. China National Nuclear Corporation Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. China National Nuclear Corporation Business Overview
Table 105. China National Nuclear Corporation Recent Developments
Table 106. Urenco Nuclear Medicine Isotopes Basic Information
Table 107. Urenco Nuclear Medicine Isotopes Product Overview
Table 108. Urenco Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Urenco Business Overview
Table 110. Urenco Recent Developments
Table 111. LANL Nuclear Medicine Isotopes Basic Information
Table 112. LANL Nuclear Medicine Isotopes Product Overview
Table 113. LANL Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. LANL Business Overview
Table 115. LANL Recent Developments
Table 116. Shanghai Engineering Research Center Nuclear Medicine Isotopes Basic Information
Table 117. Shanghai Engineering Research Center Nuclear Medicine Isotopes Product Overview
Table 118. Shanghai Engineering Research Center Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Shanghai Engineering Research Center Business Overview
Table 120. Shanghai Engineering Research Center Recent Developments
Table 121. IDB Holland Nuclear Medicine Isotopes Basic Information
Table 122. IDB Holland Nuclear Medicine Isotopes Product Overview
Table 123. IDB Holland Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. IDB Holland Business Overview
Table 125. IDB Holland Recent Developments
Table 126. NHTC Nuclear Medicine Isotopes Basic Information
Table 127. NHTC Nuclear Medicine Isotopes Product Overview
Table 128. NHTC Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. NHTC Business Overview
Table 130. NHTC Recent Developments
Table 131. Linde Nuclear Medicine Isotopes Basic Information
Table 132. Linde Nuclear Medicine Isotopes Product Overview
Table 133. Linde Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Linde Business Overview
Table 135. Linde Recent Developments
Table 136. ORNL Nuclear Medicine Isotopes Basic Information
Table 137. ORNL Nuclear Medicine Isotopes Product Overview
Table 138. ORNL Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. ORNL Business Overview
Table 140. ORNL Recent Developments
Table 141. SI Science Nuclear Medicine Isotopes Basic Information
Table 142. SI Science Nuclear Medicine Isotopes Product Overview
Table 143. SI Science Nuclear Medicine Isotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. SI Science Business Overview
Table 145. SI Science Recent Developments
Table 146. Global Nuclear Medicine Isotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Nuclear Medicine Isotopes Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Nuclear Medicine Isotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Nuclear Medicine Isotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Nuclear Medicine Isotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Nuclear Medicine Isotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Nuclear Medicine Isotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Nuclear Medicine Isotopes Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Nuclear Medicine Isotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Nuclear Medicine Isotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Nuclear Medicine Isotopes Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Nuclear Medicine Isotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Nuclear Medicine Isotopes Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Nuclear Medicine Isotopes Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Nuclear Medicine Isotopes Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Nuclear Medicine Isotopes Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Nuclear Medicine Isotopes Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Nuclear Medicine Isotopes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Isotopes Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Medicine Isotopes Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Medicine Isotopes Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Isotopes Market Size by Country (M USD)
Figure 11. Nuclear Medicine Isotopes Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Medicine Isotopes Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Medicine Isotopes Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Isotopes Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Medicine Isotopes Market Share by Type
Figure 18. Sales Market Share of Nuclear Medicine Isotopes by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Medicine Isotopes by Type in 2023
Figure 20. Market Size Share of Nuclear Medicine Isotopes by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Medicine Isotopes by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Medicine Isotopes Market Share by Application
Figure 24. Global Nuclear Medicine Isotopes Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Medicine Isotopes Sales Market Share by Application in 2023
Figure 26. Global Nuclear Medicine Isotopes Market Share by Application (2019-2024)
Figure 27. Global Nuclear Medicine Isotopes Market Share by Application in 2023
Figure 28. Global Nuclear Medicine Isotopes Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Medicine Isotopes Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Nuclear Medicine Isotopes Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Nuclear Medicine Isotopes Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Medicine Isotopes Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Nuclear Medicine Isotopes Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Nuclear Medicine Isotopes Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Nuclear Medicine Isotopes Sales Market Share by Region in 2023
Figure 44. China Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Nuclear Medicine Isotopes Sales and Growth Rate (K Units)
Figure 50. South America Nuclear Medicine Isotopes Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Nuclear Medicine Isotopes Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Nuclear Medicine Isotopes Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Nuclear Medicine Isotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Nuclear Medicine Isotopes Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Nuclear Medicine Isotopes Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Medicine Isotopes Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Medicine Isotopes Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Medicine Isotopes Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Medicine Isotopes Market Share Forecast by Application (2025-2030)
